Help!!! I’m about to share the stage at the 3rd International Acid-Base Symposium on the 25th-27th Jun, with the best acid-base researchers in the world, all of whom I actively stalk (well read and recite everything they’ve ever published but close enough!) I’m terrified and excited in equal doses…but urgently need to change my presentation approach because until now I’ve had the privileged position of simply fulfilling the town-crier role, announcing far and wide the findings of their incredible research into acid base physiology and their findings about impact of chronic mild metabolic acidosis. But I can’t quote Arnett to Arnett! I can’t tell Dawson-Hughes about the incredible insights of Dawson-Hughes’ large body of work in this area! Oh my Goodness (cue, shaking knees), I’m going to meet Thomas Remer…of Potential Renal Acid Load Formula Fame!!
Yes, my partner is a musician and through him I have brushed shoulders with all kinds of famous…but nothing that has made my heart beat quite this fast!
Must buy an autograph book for them to all sign.
Joking (kind of).
Did I tell you where it is? I’m flying to Slovakia and staying at the Smolenice Castle. Can you imagine me being Queen for a day or at least walk in the footsteps of 15th century royalty! In 1953 the castle became the property of the Slovak Academy of Science…hhhmmm wondering if we can find a castle for the Australian Naturopathic Summit in the future? And no… the Crystal Castle out the back of Mullumbimby does NOT qualify.
Alright..I know…settle down Rachel…I can do this! The exciting thing is I will be the only presenter to speak to a patient rather than population or study sample perspective at the Acid-Base Symposium, which is really different for these high level researchers. I’ll be presenting on The Measurable Clinical Impact of Alkaline Supplementation – Case Studies. There is a large body of evidence regarding chronic mild metabolic acidosis (CMMA) that essentially provides proof of this nutritional, physiological phenomenon, at the population level but attempts to translate this into the ‘n=1’ environment of the clinical context, present several challenges. Most notably, the question of whether the methods of acid burden quantification, and the CMMA diagnostic criteria applied to populations, can be used with equal validity in the individual. Secondly, the question of whether alkalising interventions induce demonstrable positive change in other active pathophysiological processes in the individual, as reflected by conventional disease markers and ultimately the patient’s clinical picture. No surprises really as many of you know this is a treatment approach I am passionate about and I have an ongoing preoccupation with trying to objectively measure everything!
Anyway wish me veľa štastia 🙂
For all you history buffs, here’s a short video on where I will be hanging out with my new besties 😉